CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
Europe - Euronext Oslo - OSL:CONTX - SE0014731154 - Common Stock
3.94 NOK
-0.12 (-2.96%)
We assign a fundamental rating of 5 out of 10 to CONTX. CONTX was compared to 11 industry peers in the Health Care Technology industry. While CONTX belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CONTX is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
In the past year CONTX had a positive cash flow from operations.
Of the past 5 years CONTX 4 years were profitable.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 7.66%, CONTX is doing good in the industry, outperforming 63.64% of the companies in the same industry.
CONTX has a Return On Equity (10.25%) which is comparable to the rest of the industry.
CONTX's Return On Invested Capital of 8.96% is fine compared to the rest of the industry. CONTX outperforms 72.73% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 9.17%.
The last Return On Invested Capital (8.96%) for CONTX is well below the 3 year average (36.72%), which needs to be investigated, but indicates that CONTX had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROIC | 8.96% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
CONTX has a Profit Margin (7.86%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CONTX has grown nicely.
With a Operating Margin value of 9.33%, CONTX perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
In the last couple of years the Operating Margin of CONTX has grown nicely.
CONTX's Gross Margin of 97.46% is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CONTX is creating value.
The number of shares outstanding for CONTX remains at a similar level compared to 1 year ago.
The number of shares outstanding for CONTX remains at a similar level compared to 5 years ago.
Compared to 1 year ago, CONTX has a worse debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of CONTX is 1.49, which is an excellent value as it means it would take CONTX, only 1.49 years of fcf income to pay off all of its debts.
CONTX's Debt to FCF ratio of 1.49 is in line compared to the rest of the industry. CONTX outperforms 54.55% of its industry peers.
CONTX has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CONTX (0.07) is better than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Altman-Z | N/A |
ROIC/WACC1.27
WACC7.08%
2.3 Liquidity
CONTX has a Current Ratio of 4.12. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CONTX (4.12) is better than 90.91% of its industry peers.
A Quick Ratio of 4.07 indicates that CONTX has no problem at all paying its short term obligations.
The Quick ratio of CONTX (4.07) is better than 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.32% over the past year.
Measured over the past years, CONTX shows a very strong growth in Earnings Per Share. The EPS has been growing by 40.02% on average per year.
CONTX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
Measured over the past years, CONTX shows a small growth in Revenue. The Revenue has been growing by 7.78% on average per year.
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
3.2 Future
Based on estimates for the next years, CONTX will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.64% on average per year.
CONTX is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.19% yearly.
EPS Next Y-28.88%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
EPS Next 5Y-10.64%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-1.19%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.76 indicates a reasonable valuation of CONTX.
Based on the Price/Earnings ratio, CONTX is valued cheaper than 100.00% of the companies in the same industry.
CONTX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.11.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.76 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CONTX is on the same level as its industry peers.
CONTX's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 48.28 | ||
| EV/EBITDA | 12.08 |
4.3 Compensation for Growth
The decent profitability rating of CONTX may justify a higher PE ratio.
A cheap valuation may be justified as CONTX's earnings are expected to decrease with -31.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.46, CONTX pays a better dividend. On top of this CONTX pays more dividend than 90.91% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, CONTX pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
OSL:CONTX (12/2/2025, 12:15:58 PM)
3.94
-0.12 (-2.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners6.92%
Inst Owner ChangeN/A
Ins Owners24%
Ins Owner ChangeN/A
Market Cap304.84M
Revenue(TTM)132.19M
Net Income(TTM)9.36M
Analysts40
Price Target4.08 (3.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-124.27%
Min EPS beat(2)-148.54%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.12%
Min Revenue beat(2)-29.34%
Max Revenue beat(2)-4.91%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.76 | ||
| Fwd PE | N/A | ||
| P/S | 2.38 | ||
| P/FCF | 48.28 | ||
| P/OCF | 20.83 | ||
| P/B | 3.11 | ||
| P/tB | 3.21 | ||
| EV/EBITDA | 12.08 |
EPS(TTM)0.45
EY11.42%
EPS(NY)0
Fwd EYN/A
FCF(TTM)0.08
FCFY2.07%
OCF(TTM)0.19
OCFY4.8%
SpS1.65
BVpS1.27
TBVpS1.23
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.58
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.66% | ||
| ROE | 10.25% | ||
| ROCE | 11.34% | ||
| ROIC | 8.96% | ||
| ROICexc | 31.76% | ||
| ROICexgc | 35.3% | ||
| OM | 9.33% | ||
| PM (TTM) | 7.86% | ||
| GM | 97.46% | ||
| FCFM | 4.93% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexgc growth 3Y-39.35%
ROICexgc growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score5
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.07 | ||
| Debt/FCF | 1.49 | ||
| Debt/EBITDA | 0.34 | ||
| Cap/Depr | 96.94% | ||
| Cap/Sales | 6.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 71.3% | ||
| Profit Quality | 62.81% | ||
| Current Ratio | 4.12 | ||
| Quick Ratio | 4.07 | ||
| Altman-Z | N/A |
F-Score5
WACC7.08%
ROIC/WACC1.27
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.32%
EPS 3Y40.02%
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y-28.88%
EPS Next 2Y-41.42%
EPS Next 3Y-31.69%
EPS Next 5Y-10.64%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y11.74%
Revenue growth 5Y7.78%
Sales Q2Q%-21.24%
Revenue Next Year-5.88%
Revenue Next 2Y-6.15%
Revenue Next 3Y-3.72%
Revenue Next 5Y-1.19%
EBIT growth 1Y-64.61%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-32.14%
EBIT Next 3Y9.74%
EBIT Next 5YN/A
FCF growth 1Y-82.88%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-68.39%
OCF growth 3Y51.49%
OCF growth 5Y5.6%
CONTEXTVISION AB / CONTX.OL FAQ
What is the ChartMill fundamental rating of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a fundamental rating of 5 / 10 to CONTX.OL.
What is the valuation status of CONTEXTVISION AB (CONTX.OL) stock?
ChartMill assigns a valuation rating of 4 / 10 to CONTEXTVISION AB (CONTX.OL). This can be considered as Fairly Valued.
How profitable is CONTEXTVISION AB (CONTX.OL) stock?
CONTEXTVISION AB (CONTX.OL) has a profitability rating of 7 / 10.
How financially healthy is CONTEXTVISION AB?
The financial health rating of CONTEXTVISION AB (CONTX.OL) is 6 / 10.
Can you provide the expected EPS growth for CONTX stock?
The Earnings per Share (EPS) of CONTEXTVISION AB (CONTX.OL) is expected to decline by -28.88% in the next year.